SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is a top trending stock following its latest earnings report, which, despite beating estimates, sparked a significant market downturn due to cautious forward guidance and concerns over slowing sales in China and the impact of tariffs. Community discussions highlight strong disappointment with management's conference call performance, yet many investors are actively debating if this sharp decline represents a compelling long-term buying opportunity.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending after reports confirmed a binding agreement for a US joint venture involving TikTok's operations, with Oracle joining as a key investor and cloud provider. This news is fueling bullish sentiment, as many investors believe it significantly validates Oracle's cloud infrastructure and AI strategy, potentially outweighing recent debt concerns. Conversely, some in the community remain cautious, continuing to highlight the company's substantial debt load and questioning the long-term financial upside of the deal.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending amidst significant price declines, driven by broader crypto market weakness and anticipation of the Bank of Japan's interest rate decision. Community sentiment is polarized, with many expressing frustration over persistent drops, while strong proponents emphasize institutional accumulation and buying the dip, confident in its long-term utility for global financial infrastructure.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is gaining attention following a new strategic partnership with C Speed, signaling a deeper push into AI-enabled border security and defense. The community is actively discussing the potential for significant government and military AI contracts, alongside the upcoming shareholder vote on increasing authorized shares, seen as a pivotal move for future strategic growth and acquisitions in the AI defense sector.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending with significant momentum, primarily driven by high anticipation for an imminent NASA Lunar Terrain Vehicle (LTV) contract award, coupled with recent bullish analyst coverage and strong trading volume. The community is actively discussing LUNR's strategic advantage in lunar infrastructure, the potential for a substantial short squeeze, and broader market optimism for the space sector following an executive order on American space superiority.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as the Federal Reserve recently enacted a rate cut and announced T-bill purchases, intended to inject liquidity and influence rates. While some investors anticipate further rate cuts and point to institutional bullish positions from Soros and JPMorgan, a significant portion of the community questions the efficacy of these moves as long-term yields remain stubbornly high or are even rising. This dynamic creates a sharp division among market participants, debating whether the economy is truly headed for disinflation, which would favor bonds, or if persistent inflation and potential political influence on the Fed will keep long-duration Treasuries contentious.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending amidst overwhelming community frustration, with many holders lamenting significant recent losses and questioning its legitimacy as a 'shitcoin' or 'scam'. The pervasive negative sentiment reflects widespread disillusionment with its performance over the past few months, as some feel punished for their loyalty while others, though fewer, maintain hope for a rebound.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending amidst significant trading volume and positive clinical data for its CAN-2409 immunotherapy across prostate, pancreatic, and lung cancers. The community is actively discussing the stock's perceived undervaluation, anticipating a substantial short squeeze fueled by high short interest. Many speculate about an imminent partnership or acquisition, believing its oncology pipeline holds multi-billion dollar market potential.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia Technologies is trending due to recent analyst upgrades, including a new "Buy" rating and an $18 price target from Benchmark, fueling investor optimism. The community is highly anticipating strong Black Friday sales results and discussing the company's long-term growth potential within the expanding African e-commerce market, despite acknowledging past volatility.

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Athira Pharma Inc

Athira Pharma is trending following its announcement of exclusively licensing a late-stage breast cancer drug program and securing substantial financing to advance its development. This news has ignited significant trading volume, with many anticipating a potential short squeeze fueled by the low float, while others express caution regarding potential dilution and the stock's historical volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Receives Consensus Recommendation of "Buy" from Analysts

Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) has earned an average recommendation of "Buy" from the nine analysts that are covering the company, MarketBeat.com reports. One analyst has...

Spyre Therapeutics (NASDAQ:SYRE) Hits New 52-Week High - Should You Buy?

Spyre Therapeutics (NASDAQ:SYRE) Sets New 12-Month High - Here's What Happened...

Spyre Therapeutics (NASDAQ:SYRE) Trading Up 7.2% - Still a Buy?

Spyre Therapeutics (NASDAQ:SYRE) Trading Up 7.2% - What's Next...

Spyre Therapeutics (NASDAQ:SYRE) CEO Cameron Turtle Sells 15,000 Shares

Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) CEO Cameron Turtle sold 15,000 shares of Spyre Therapeutics stock in a transaction dated Monday, December 1st. The stock was sold at an...

Spyre Therapeutics (NASDAQ:SYRE) Sets New 12-Month High on Analyst Upgrade

Spyre Therapeutics (NASDAQ:SYRE) Reaches New 52-Week High on Analyst Upgrade...

Spyre Therapeutics (NASDAQ:SYRE) Upgraded by Jones Trading to Buy Rating

Jones Trading upgraded shares of Spyre Therapeutics from a "hold" rating to a "buy" rating and set a $64.00 target price for the company in a research note on Monday...

Spyre Therapeutics, Inc. $SYRE Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH lessened its holdings in Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) by 9.2% in the second quarter, according to the company in its most...

Spyre Therapeutics (NASDAQ:SYRE) Reaches New 52-Week High - Here's What Happened

Spyre Therapeutics (NASDAQ:SYRE) Reaches New 1-Year High - Time to Buy...

Foresite Capital Management VI LLC Makes New Investment in Spyre Therapeutics, Inc. $SYRE

Foresite Capital Management VI LLC acquired a new stake in Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and...

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Receives Average Recommendation of "Buy" from Brokerages

Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) have earned an average rating of "Buy" from the eight ratings firms that are covering the stock, MarketBeat Ratings reports. One...

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe on December 16, 2013 and is headquartered in Waltham, MA.

Spyre Therapeutics Inc.

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.70	--	--	N/A
Q3 '25	-$0.76	-$0.15	80.28%	BEAT
Q2 '25	-$0.75	-$0.49	34.98%	BEAT
Q1 '25	-$0.84	-$0.60	28.66%	BEAT
Q4 '24	-$0.99	-$0.81	18.41%	BEAT

SYRE
Aeglea BioTherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SYRE News

SYREAeglea BioTherapeutics Inc